Clinical Utility of Survivin Messenger Ribosomal Nucleic Acid by Reverse Transcriptase-Polymerase Chain Reaction in Bladder Cancer Patients

Magy Samir Maiz;

Abstract


Bladder cancer ranks fourth in incidence among all cancers in males and ninth in females worldwide. Males have fourfold excess of bladder cancer compared to females. Despite the marked decrease in prevalence of endemic bilharziasis over the last two decad


Other data

Title Clinical Utility of Survivin Messenger Ribosomal Nucleic Acid by Reverse Transcriptase-Polymerase Chain Reaction in Bladder Cancer Patients
Authors Magy Samir Maiz
Keywords Clinical Utility of Survivin Messenger Ribosomal Nucleic Acid by Reverse Transcriptase-Polymerase Chain Reaction in Bladder Cancer Patients
Issue Date 2009
Description 
Bladder cancer ranks fourth in incidence among all cancers in males and ninth in females worldwide. Males have fourfold excess of bladder cancer compared to females. Despite the marked decrease in prevalence of endemic bilharziasis over the last two decad

Attached Files

File SizeFormat
Magy_Samir_Final Thesis last correction.pdf594.32 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 9 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.